LINC00511 drives osimertinib resistance in LUAD via PERK kinase: A clinical biomarker with enzymatic therapeutic potential
Year: 2026
Type: article
Source: Cellular Signalling
Institutions: Kunming Medical University, Peking University Cancer Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Award: G2945737466
OpenAlex ID: W7204227218
